top of page

Rajesh Exports Shares Extend Decline After Founder Declines to Challenge Sebi Order

Rajesh Exports shares have fallen nearly 27 percent since Sebi issued an interim order alleging revenue overstatement of about Rs 15.15 lakh crore between FY21 and FY25. The stock hit its sixth consecutive lower circuit after founder and CEO Rajesh Mehta said he would not challenge the regulator's findings and would continue cooperating with the investigation.

By Finblage Editorial Desk

10:55 am

11 June 2026

Shares of Rajesh Exports continued to remain under pressure, falling for the sixth straight trading session after founder and CEO Rajesh Mehta stated that he would not challenge Sebi's interim order issued on June 3.


The stock was locked in the 5 percent lower circuit at Rs 80.43 on the NSE on Thursday, extending its decline to nearly 27 percent from Rs 109.99 recorded on June 3. The sustained selling follows regulatory concerns raised by the Securities and Exchange Board of India regarding the company's financial disclosures.


In its interim order, Sebi alleged that Rajesh Exports overstated its consolidated revenue by approximately Rs 15.15 lakh crore during the period from FY21 to FY25. According to the regulator, the alleged inflation was linked to revenues reported from overseas subsidiaries, particularly Switzerland-based Valcambi SA.


Sebi stated that while Rajesh Exports reported substantial revenues from its foreign subsidiaries in its consolidated financial statements, the audited standalone financial statements of those entities reflected significantly lower figures. The regulator also raised concerns about a prima facie misrepresentation of the company's financial position, noting that a large portion of the reported revenue originated from overseas subsidiaries whose financial statements were not publicly disclosed.


Responding to the allegations, Rajesh Mehta said he would cooperate fully with the ongoing regulatory process and would not contest the interim order. Speaking to PTI, he rejected claims that the company had obstructed Sebi's investigation and maintained that all requested documents had been provided during the audit process.


Mehta stated that any discrepancies identified by the regulator would be reconciled during the course of the investigation. He emphasized that the company had consistently cooperated with Sebi and denied withholding any relevant information.


The Sebi probe and the subsequent sharp correction in the stock have intensified investor concerns regarding the company's reported financial performance and disclosure practices.

Sources & Disclaimer

This article is compiled from publicly available information, including company disclosures, stock exchange filings, regulatory announcements, and reports from global and domestic financial publications. The content has been editorially reviewed and enhanced by the Finblage Editorial Desk for clarity and investor awareness purposes only.

All information provided on Finblage is strictly for educational and informational use and should not be considered as financial, investment, legal, or professional advice. Readers are advised to conduct their own independent research and consult a certified financial advisor before making any investment decisions. Finblage shall not be held responsible for any losses arising from the use of information published on this website.

Premium Edition

Copilot_20260121_132432.png
crown.png

Insight

India's 2026 Monsoon : When the Rain Becomes a Risk

After two consecutive years of above-normal rainfall, India faces a significantly weaker 2026 southwest monsoon, with meteorological agencies forecasting rainfall at around 90% of the Long Period Average amid rising El Niño risks. A deficient monsoon could weigh on agricultural output, rural incomes, food inflation, and overall economic growth, while creating sector-specific winners and losers across the equity market.

5 July 2026

Continue

Latest Market Insights

India Merchandise Trade Deficit Widens In June As Imports Outpace Export Growth

14 July 2026

India Indonesia Strategic Partnership Expands Across Defense Critical Minerals and Technology

8 July 2026

India Approves Defence Deals Worth 52000 Crore to Boost Military Strength and Domestic Manufacturing

7 July 2026

Merger & Acquisition

Yatharth Hospital Expands Delhi NCR Presence Through Gurugram Hospital Asset Acquisition

14 May 2026

Sun Pharma Acquisition of Organon Strategic Expansion and Global Positioning Shift

28 April 2026

Varun Beverages Expands Beyond Soft Drinks with ₹131 Crore South Africa Dairy Acquisition

18 March 2026

whatsapp-call-icon-psd-editable_314999-3

Whatsapp Channel

Want stock insights, market trends, and exclusive research updates in real-time? Don’t miss out – Finblage is now on WhatsApp!

bottom of page